Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for inhibiting fibrogenesis by an rhdecorin-fc fusion protein

A decorin, fusion protein technology, applied in proteoglycan, biochemical equipment and methods, fusion polypeptides, etc., can solve the problem of applying decorin without Fc fragment

Inactive Publication Date: 2008-01-30
杨梦苏 +4
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, none of these patents applied the Fc fragment to decorin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for inhibiting fibrogenesis by an rhdecorin-fc fusion protein
  • Method for inhibiting fibrogenesis by an rhdecorin-fc fusion protein
  • Method for inhibiting fibrogenesis by an rhdecorin-fc fusion protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] Inhibition of hepatic fibrogenesis in rats by rh-decorin

[0051] Materials and methods, animals and experimental design

[0052] All experiments were performed using accepted ethical guidelines. Male Wistar rats (Beijing Medical University) weighing 200-250 g were used in this study. Animals had free access to food and drinking water. 40% CCl4 (Sigma) was prepared by mixing CCl4 with olive oil. Liver injury and fibrosis were induced by subcutaneous injection of 40% CCl4 at 3 ml / kg body weight twice a week for 8 weeks. CCl4 control animals received olive oil only.

[0053] rhDecorin was administered intraperitoneally at a dose of 20 μg / kg / d body weight per day. RhDecorin was extracted from the culture medium of Cos-7 cells transfected with decorin.

[0054] In this way, 3 groups can be distinguished, each group comprising 7 animals. Group I: olive oil only; Group II: 40% CCl4; Group III: 40% CCl4 plus rhDecorin. rhDecorin treatment was started at the third w...

Embodiment 2

[0076] rhDecorin and rhDecorin-Fc suppress fibroblasts by inhibiting HSC cell activation Dimensional occurrence

[0077] To elucidate the role of rhDecorin and rhDecorin-Fc in fibrogenesis, the effects of rhDecorin and rhDecorin-Fc on the activation of HSC cells stimulated by TGF-β1 were examined. HSC activation is a fundamental process in hepatic fibrogenesis. It presents as proliferation of HSCs and remodeling of the extracellular matrix, including, degradation of collagen IV in the basement membrane and deposition of excess extracellular matrix components such as collagen I and collagen III, and expression of MMPs and TIMPs Changes in mRNA levels. TGF-β1 is one of the most important activators in this process.

[0078] Materials and methods

[0079] cell

[0080] The inventors used an established human HSC cell line called LX-2. These cells are well characterized and show many similarities to HSC primary cultures.

[0081] rh decorin

[0082] The full-lengt...

Embodiment 3

[0099] 1. Construction of the gene encoding hDecorin-Fc fusion protein

[0100] Fusion proteins are assembled from several DNA fragments. To obtain the genes encoding the leader peptide and human decorin mature protein, total RNA was extracted from human fibroblasts and subjected to RT-PCR to clone decorin. Table 3 shows the oligonucleotide sequences used to clone the hDecorin-Fc fusion protein. The resulting DNA fragment, approximately 1077 bp in length, was inserted directly into a directional TOPO cloning vector, such as pCDNA 3.1 (Invetrogen), according to the manufacturer's instructions. Confirmation of human decorin gene sequence by DNA sequencing.

[0101] The gene encoding the Fc region or fragment (Fc.sub..gamma.1) of human IgG1 was obtained by reverse transcription and PCR using RNA prepared from human lymphocytes and appropriate 5' and 3' primers (Table 3) . The resulting Fc.sub..gamma.1 DNA fragment containing partial sequences of the hinge, CH2 and CH3 domai...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to methods for inhibiting liver fibrogenesis in vitro and / or in vivo with directly administered recombinant rhDecorin and rhDecorin-Fc fusion protein. In one embodiment a linker is provided between Decorin and the Fc hinge fragment to form a fusion protein which increases the biologic activity of Decorin and increases the ability to bind to TGF-ß and extends the lifetime of decorin in serum, where the Fc hinge fragment is a modified form of Fc involving the replacement of four N-terminal amino acids with ten different amino acids which extends the lifetime of the Decorin-Fc protein by 50%.

Description

field of invention [0001] The present invention relates to methods of inhibiting fibrogenesis, especially hepatic fibrogenesis, by administering antagonists of hepatic stellate cell activation and fibroblast activation. The present invention also relates to the preparation of fusion protein constructs and the production of fusion proteins. Background of the invention [0002] With regard to liver fibrosis, fibrosis plays an integral role in the final consensus pathway of structural remodeling that reduces normal organ function after injury. It is one of the most fundamentally damaging and least desirable responses to developmental or inflammatory disease, and has been observed in millions of individuals at advanced stages of many different disease processes after exposure to hyperoxia Such diseases include, for example, cystic fibrosis, interstitial nephritis, liver cirrhosis, and pulmonary fibrosis. Liver fibrosis is characterized by excessive deposition of extracellular ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/64C12N15/12C07K14/435A61K38/16A61P1/16
CPCC07K14/4725C07K2319/30A61P1/16
Inventor 杨梦甦孔祥复张雅鸥郑思敏张碧源
Owner 杨梦苏
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com